Suppr超能文献

为什么免疫蛋白酶体亚基低分子量多肽 2 的结构而不是其活性可以挽救抗原呈递。

Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation.

机构信息

Biotechnology Institute Thurgau, Constance University, CH-8280 Kreuzlingen, Switzerland.

出版信息

J Immunol. 2012 Aug 15;189(4):1868-77. doi: 10.4049/jimmunol.1103592. Epub 2012 Jul 6.

Abstract

The proteasome is responsible for the generation of most epitopes presented on MHC class I molecules. Treatment of cells with IFN-γ leads to the replacement of the constitutive catalytic subunits β1, β2, and β5 by the inducible subunits low molecular mass polypeptide (LMP) 2 (β1i), multicatalytic endopeptidase complex-like-1 (β2i), and LMP7 (β5i), respectively. The incorporation of these subunits is required for the production of numerous MHC class I-restricted T cell epitopes. The structural features rather than the proteolytic activity of an immunoproteasome subunit are needed for the generation of some epitopes, but the underlying mechanisms have remained elusive. Experiments with LMP2-deficient splenocytes revealed that the generation of the male HY-derived CTL-epitope UTY(246-254) was dependent on LMP2. Treatment of male splenocytes with an LMP2-selective inhibitor did not reduce UTY(246-254) presentation, whereas silencing of β1 activity increased presentation of UTY(246-254). In vitro degradation experiments showed that the caspase-like activity of β1 was responsible for the destruction of this CTL epitope, whereas it was preserved when LMP2 replaced β1. Moreover, inhibition of the β5 subunit rescued the presentation of the influenza matrix 58-66 epitope, thus suggesting that a similar mechanism can apply to the exchange of β5 by LMP7. Taken together, our data provide a rationale why the structural property of an immunoproteasome subunit rather than its activity is required for the generation of a CTL epitope.

摘要

蛋白酶体负责生成 MHC I 类分子上呈现的大多数表位。用 IFN-γ 处理细胞会导致组成型催化亚基β1、β2 和β5 分别被诱导型亚基低分子量多肽(LMP)2(β1i)、多催化内肽酶复合物样-1(β2i)和 LMP7(β5i)取代。这些亚基的掺入对于产生许多 MHC I 类限制的 T 细胞表位是必需的。对于一些表位,需要免疫蛋白酶体亚基的结构特征而不是蛋白水解活性,但其潜在机制仍不清楚。用 LMP2 缺陷脾细胞进行的实验表明,男性 HY 衍生的 CTL 表位 UTY(246-254)的产生依赖于 LMP2。用 LMP2 选择性抑制剂处理雄性脾细胞不会降低 UTY(246-254)的呈递,而β1 活性的沉默增加了 UTY(246-254)的呈递。体外降解实验表明,β1 的半胱氨酸蛋白酶样活性负责破坏这种 CTL 表位,而当 LMP2 取代β1 时,它被保留下来。此外,β5 亚基的抑制恢复了流感基质 58-66 表位的呈递,因此表明类似的机制可能适用于 LMP7 取代β5。总之,我们的数据提供了为什么免疫蛋白酶体亚基的结构特性而不是其活性对于 CTL 表位的产生是必需的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验